345 related articles for article (PubMed ID: 16597622)
1. Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody.
Prabakaran P; Gan J; Feng Y; Zhu Z; Choudhry V; Xiao X; Ji X; Dimitrov DS
J Biol Chem; 2006 Jun; 281(23):15829-36. PubMed ID: 16597622
[TBL] [Abstract][Full Text] [Related]
2. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R.
Hwang WC; Lin Y; Santelli E; Sui J; Jaroszewski L; Stec B; Farzan M; Marasco WA; Liddington RC
J Biol Chem; 2006 Nov; 281(45):34610-6. PubMed ID: 16954221
[TBL] [Abstract][Full Text] [Related]
4. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein.
He Y; Li J; Li W; Lustigman S; Farzan M; Jiang S
J Immunol; 2006 May; 176(10):6085-92. PubMed ID: 16670317
[TBL] [Abstract][Full Text] [Related]
5. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
6. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.
Yi C; Sun X; Ye J; Ding L; Liu M; Yang Z; Lu X; Zhang Y; Ma L; Gu W; Qu A; Xu J; Shi Z; Ling Z; Sun B
Cell Mol Immunol; 2020 Jun; 17(6):621-630. PubMed ID: 32415260
[TBL] [Abstract][Full Text] [Related]
7. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.
Lan J; Ge J; Yu J; Shan S; Zhou H; Fan S; Zhang Q; Shi X; Wang Q; Zhang L; Wang X
Nature; 2020 May; 581(7807):215-220. PubMed ID: 32225176
[TBL] [Abstract][Full Text] [Related]
8. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
10. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.
Li F; Li W; Farzan M; Harrison SC
Science; 2005 Sep; 309(5742):1864-8. PubMed ID: 16166518
[TBL] [Abstract][Full Text] [Related]
11. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.
He Y; Zhu Q; Liu S; Zhou Y; Yang B; Li J; Jiang S
Virology; 2005 Mar; 334(1):74-82. PubMed ID: 15749124
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
Tai W; He L; Zhang X; Pu J; Voronin D; Jiang S; Zhou Y; Du L
Cell Mol Immunol; 2020 Jun; 17(6):613-620. PubMed ID: 32203189
[TBL] [Abstract][Full Text] [Related]
13. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.
Tian X; Li C; Huang A; Xia S; Lu S; Shi Z; Lu L; Jiang S; Yang Z; Wu Y; Ying T
Emerg Microbes Infect; 2020; 9(1):382-385. PubMed ID: 32065055
[TBL] [Abstract][Full Text] [Related]
14. The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterization.
Chakraborti S; Prabakaran P; Xiao X; Dimitrov DS
Virol J; 2005 Aug; 2():73. PubMed ID: 16122388
[TBL] [Abstract][Full Text] [Related]
15. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections.
Li F
J Virol; 2008 Jul; 82(14):6984-91. PubMed ID: 18448527
[TBL] [Abstract][Full Text] [Related]
16. Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV.
Jiang W; Wang J; Jiao S; Gu C; Xu W; Chen B; Wang R; Chen H; Xie Y; Wang A; Li G; Zeng D; Zhang J; Zhang M; Wang S; Wang M; Gui X
MAbs; 2021; 13(1):1953683. PubMed ID: 34313527
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Antibody Effectiveness Is Influenced by Non-Epitope Mutation/Binding-Induced Denaturation of the Epitope 3D Architecture.
Malisheni MM; Bates M; Rizvanov AA; MacAry PA
Pathogens; 2022 Nov; 11(12):. PubMed ID: 36558771
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.
He Y; Li J; Du L; Yan X; Hu G; Zhou Y; Jiang S
Vaccine; 2006 Jun; 24(26):5498-508. PubMed ID: 16725238
[TBL] [Abstract][Full Text] [Related]
19. Computational characterization and design of SARS coronavirus receptor recognition and antibody neutralization.
Zhang Y; Zheng N; Zhong Y
Comput Biol Chem; 2007 Apr; 31(2):129-33. PubMed ID: 17374510
[TBL] [Abstract][Full Text] [Related]
20. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies.
Zhu Z; Chakraborti S; He Y; Roberts A; Sheahan T; Xiao X; Hensley LE; Prabakaran P; Rockx B; Sidorov IA; Corti D; Vogel L; Feng Y; Kim JO; Wang LF; Baric R; Lanzavecchia A; Curtis KM; Nabel GJ; Subbarao K; Jiang S; Dimitrov DS
Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12123-8. PubMed ID: 17620608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]